For relevance BD1 has 5 quarters of cash left we all know how fast medi companies burn cash on R and D and their ROE (return on equity) is almost negative permanently (9/10 years) ditto their earnings; ZNO does not need to answer the question of cash quarters because it is cash flow positive every quarter. Further their ROE fy '20 was near +80%. I'll stay the course with the profitable one thanks.
For relevance BD1 has 5 quarters of cash left we all know how...
Add ZNO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.006(9.84%) |
Mkt cap ! $11.75M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.2¢ | $3.942K | 69.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 361 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 199999 | 1 |
View Market Depth
| Last trade - 15.24pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.7¢ |
Change
-0.006 ( 6.56 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.7¢ | 5.2¢ | 56191 | ||
| Last updated 13.52pm 26/04/2024 ? | |||||
| ZNO (ASX) Chart |